EUVIMEDEUVIMED entdecken
Crossref

SERS-based lateral flow immunoassay for rapid and sensitive sensing of nucleocapsid protein toward SARS-CoV-2 screening in clinical samples

Weixia Zhi, Lingwei Wang, Li Dai, Jing Xu, Tingting He, Xiangxin Zong, Jun Xu, Huaihong Cai, Jiang Pi, Pinghua Sun, Shanze Chen, Xueqin Huang und 1 weitere

Analytica Chimica Acta · 2025-07 · 1360 · 344149

DOI: 10.1016/j.aca.2025.344149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025-07. Verfasst von Weixia Zhi und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College (Shenzhen People's Hospital), The Fifth Affiliated Hospital, College of Pharmacy, Jinan University, Guangzhou, 51…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, Spectrum Analysis, Raman. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, K. C. Wong Education Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early and accurate identification of SARS-CoV-2 infection is crucial for epidemic prevention and control. Lateral flow immunoassay (LFIA) has become the mainstream method for screening SARS-CoV-2 infection due to its rapid, simple and amenable for point-of-care detection (POCT), but still suffered from the poor sensitivity and accuracy. In this study, Au nanoparticles (NPs) with controllable Ag shell (Au@Ag) were manufactured via a seed-mediated growth method. The Au@Ag-based LFIA exhibited superb colorimetric (CM) signal and intense surface-enhanced Raman scattering (SERS) signal for dual-mode sensing of nucleocapsid protein (N protein), a naturally protein expression in vivo during SARS-CoV-2 infection. The limit of detection (LOD) of the SERS-LFIA mode was 2.16 pg/mL, which was around 150-time more sensitive than conventional visual CM-LFIA mode (300 pg/mL). More importantly, the proposed LFIA is capable of quantitatively detecting N protein-spiked real samples with satisfactory recoveries from 83 % to 91.4 %. Clinical pharyngeal swab samples of the infected patients (n = 20) and healthy subjects (n = 20) were effectively discriminated in the developed SERS-LFIA, where the negative accuracy rate was 100 % and the positive accuracy rate was 85 %, among which samples from P1, P18, and P19 were false-negative results. The results obtained from the LFIA immunoassay were in good agreement with the standard PCR method in clinic, and superior to those of the commercially colloidal gold strip by using the same antibodies. In conclusion, the LFIA proposed here can perform specific, rapid, and ultrasensitive analysis of N protein toward early warning of SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Coronavirus Nucleocapsid ProteinsSpectrum Analysis, RamanNucleocapsid ProteinsHumansImmunoassayMetal NanoparticlesGoldLimit of DetectionSilverPhosphoproteins

Stichwörter der Autor:innen

Lateral flow immunoassayPOCTSARS-CoV-2 detectionSurface-enhanced Raman scattering

Substanzen

GoldCoronavirus Nucleocapsid ProteinsSilvernucleocapsid phosphoprotein, SARS-CoV-2Nucleocapsid ProteinsPhosphoproteins

Autor:innen und Institutionen

  • The Second Clinical Medical College (Shenzhen People's Hospital), The Fifth Affiliated Hospital, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
  • College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, China.
  • Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan, 523000, China.
  • The Second Clinical Medical College (Shenzhen People's Hospital), The Fifth Affiliated Hospital, College of Pharmacy, Jinan University, Guangzhou, 510632, China; Institute for Safflower Industry Research, Key Laboratory…
  • The Second Clinical Medical College (Shenzhen People's Hospital), The Fifth Affiliated Hospital, College of Pharmacy, Jinan University, Guangzhou, 510632, China. Electronic address: chenshanze@mail.sustech.edu.cn.
  • Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan, 523000, China. Electronic address: xqhu…

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • K. C. Wong Education Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Jinan University

Zitieren

APA

Zhi, W., Wang, L., Dai, L., Xu, J., He, T., Zong, X., Xu, J., Cai, H., Pi, J., Sun, P., Chen, S., Huang, X., & Zhou, H. (2025). SERS-based lateral flow immunoassay for rapid and sensitive sensing of nucleocapsid protein toward SARS-CoV-2 screening in clinical samples. Analytica Chimica Acta, 1360, 344149. https://doi.org/10.1016/j.aca.2025.344149

Vancouver

Zhi W, Wang L, Dai L, Xu J, He T, Zong X, et al. SERS-based lateral flow immunoassay for rapid and sensitive sensing of nucleocapsid protein toward SARS-CoV-2 screening in clinical samples. Analytica Chimica Acta. 2025;1360:344149. doi:10.1016/j.aca.2025.344149

BibTeX
@article{Zhi2025,
  author = {Zhi, Weixia and Wang, Lingwei and Dai, Li and Xu, Jing and He, Tingting and Zong, Xiangxin and Xu, Jun and Cai, Huaihong and Pi, Jiang and Sun, Pinghua and Chen, Shanze and Huang, Xueqin and Zhou, Haibo},
  title = {SERS-based lateral flow immunoassay for rapid and sensitive sensing of nucleocapsid protein toward SARS-CoV-2 screening in clinical samples},
  journal = {Analytica Chimica Acta},
  year = {2025},
  volume = {1360},
  pages = {344149},
  doi = {10.1016/j.aca.2025.344149}
}
Kostenlos starten →